Craig Felberg, VP, R&D and Clinical Affairs at STAAR SURGICAL CO (STAA), sold 800 shares at $11.15 ($119K) on 2012-03-02, disclosed to the SEC on 2012-03-06.
Scheduled sale ($119k) by VP, R&D and Clinical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.95 | 100 | $1K | 0.9% |
| 2 | $10.96 | 100 | $1K | 0.9% |
| 3 | $11.00 | 100 | $1K | 0.9% |
| 4 | $11.01 | 100 | $1K | 0.9% |
| 5 | $11.04 | 100 | $1K | 0.9% |
| 6 | $11.07 | 100 |
| $1K |
| 0.9% |
| 7 | $11.15 | 100 | $1K | 0.9% |
| 8 | $1111.00 | 100 | $111K | 93.5% |
| Total | $148.52 avg | 800 | $119K | 100% |
| Filing → |